Eli Lilly | Salg



Sales Endring Dato
AbbVie USD 15.1B 642M 2024-12
Abbott USD 10.97B 370M 2024-12
ALKERMES USD 430M 51.9M 2024-12
Amgen USD 9.09B 583M 2024-12
AstraZeneca USD 14.89B 1.32B 2024-12
Baxter International USD 2.75B 54M 2024-12
Biogen USD 2.45B 11.1M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Drreddys Laboratories INR 83.59B 3.42B 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Gilead Sciences USD 7.57B 24M 2024-12
GlaxoSmithKline GBP 8.12B 108M 2024-12
Glaxosmithkline GBP 8.12B 105M 2024-12
Indivior 298M 9M 2024-12
J&J USD 22.52B 49M 2024-12
Medtronic USD 8.29B 111M 2025-01
Merck USD 15.62B 1.03B 2024-12
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Novartis USD 13.15B 330M 2024-12
Novartis USD 13.56B 386M 2024-12
Novo Nordisk 85.68B 14.37B 2024-12
Perrigo USD 1.14B 50.8M 2024-12
Pfizer USD 17.76B 61M 2024-12
Prestige Brands USD 290.32M 6.53M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 10.56B 2.88B 2024-12
Sanofi EUR 11.26B 3.5B 2024-12
United Therapeutics USD 735.9M 13M 2024-12
Zoetis USD 2.32B 71M 2024-12



Eli Lilly Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.